Arunabio - About the company
Arunabio is a series B company based in Athens (United States), founded in 2003. It operates as a Developer of a neural exosome platform to design therapeutics for the treatment of neurodegenerative diseases. Arunabio has raised $33.1M in funding from Eshelman Ventures. The company has 213 active competitors, including 35 funded and 32 that have exited. Its top competitors include companies like BioLife Solutions, Integrated DNA Technologies and RoosterBio.
Company Details
Developer of a neural exosome platform to design therapeutics for the treatment of neurodegenerative diseases. The platform develops neural exosomes to cross the blood-brain barrier and enhance the body's anti-inflammatory, self-repair, and protective mechanisms to treat a range of neurodegenerative disorders. The lead candidate drug AB126 is developed to treat stroke, Parkinson's, and multiple sclerosis
- Website
- www.arunabio.com/
- Phone Number
- +1 **********
Key Metrics
Founded Year
2003
Location
Athens, United States
Stage
Series B
Total Funding
$33.1M in 21 rounds
Latest Funding Round
Investors
Ranked
15th among 213 active competitors
Employee Count
27 as on Aug 31, 2026
Similar Companies
Legal entities associated with Arunabio
Arunabio is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Aruna Biomedical Inc CIN: 1447734 , United States, Active | $1 - $1M (As on Jul 19, 2018) | - | - | |
Aruna Bio, Inc. CIN: 1447734 , United States, Active | $1 - $1M (As on Aug 01, 2019) | - | - |
Sign up to download Arunabio's company profile
Arunabio's funding and investors
Arunabio has raised a total funding of $33.1M over 21 rounds. Its latest funding round was a Grant (prize money) round on Aug 07, 2025 for $*****. 1 investor participated in its latest round. Arunabio has 8 institutional investors.
Here is the list of recent funding rounds of Arunabio:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 07, 2025 | 4295909 | Grant (prize money) | 9376538 | 5851218 | 5767024 | 8007486 |
Jun 01, 2022 | 3046275 | Grant (prize money) | 4502573 | 1942184 | 4098790 | |
Apr 14, 2021 | 5477107 | Series B | 4256966 | 3456870 | 2197453 | 6072302 |
View details of Arunabio's funding rounds and investors
Arunabio's founders and board of directors
Founder? Claim ProfileArunabio's employee count trend
Arunabio has 27 employees as of Aug 26. Here is Arunabio's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Arunabio's Competitors and alternates
Top competitors of Arunabio include BioLife Solutions, Integrated DNA Technologies and RoosterBio. Here is the list of Top 10 competitors of Arunabio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | BioLife Solutions 1987, Bothell (United States), Acquired | Developer of cell and gene therapies with the integrity of a single cell | - | - | 67/100 |
2nd | Integrated DNA Technologies 1987, Coralville (United States), Acquired | Provider of oligonucleotide-based reagents and kits | - | 63/100 | |
3rd | RoosterBio 2012, Frederick (United States), Series B | Developer of human mesenchymal stem cells and extracellular vesicles | $38.4M | 57/100 | |
4th | Cell culture reagents for stem cell research | $18.2M | 56/100 | ||
5th | Evox Therapeutics 2016, Oxford (United Kingdom), Series C | Developer of exosome-based therapeutics for severe neurological and rare diseases | $156M | 53/100 | |
6th | Shanghai Doning Biotechnology 2005, Shanghai (China), Series C | Provider of cell culture media | $14.9M | 53/100 | |
7th | ArcticZymes 2009, Tromso (Norway), Public | Developer of recombinant enzymes from various arctic species | - | 49/100 | |
8th | Ribometrix 2016, Raleigh (United States), Series A | Provider RNA-targeted drug discovery platform | $65.3M | 49/100 | |
9th | Toyobo 1882, New York City (United States), Public | Manufacturer of high performance materials including films and functional textiles | - | - | 49/100 |
10th | Multus 2019, London (United Kingdom), Series A | Provider of lab-grown meat alternatives | $9.3M | 45/100 | |
15th | Arunabio 2003, Athens (United States), Series B | Developer of a neural exosome platform to design therapeutics for the treatment of neurodegenerative diseases | $33.1M | 44/100 |
Looking for more details on Arunabio's competitors? Click here to see the top ones
Arunabio's Investments and acquisitions
Arunabio has made no investments or acquisitions yet.
Reports related to Arunabio
Here is the latest report on Arunabio's sector:
News related to Arunabio
•
Aruna Bio Announces Issuance Of U.s. Patent For Method Of Use For Neural Exosomes Used To Reduce Inflammation In The BrainGlobeNewswire•Aug 19, 2024•Arunabio
•
•
Aruna Bio Announces Issuance of U.S. Patent for Composition of Matter for Neural Exosomes Used to Deliver Therapeutics to the BrainGlobeNewswire•Jul 16, 2024•Arunabio
•
Aruna BIO Establishes Stroke Advisory Board to Advance Lead Program, AB126 into the ClinicBioSpace•Mar 04, 2024•Arunabio
•
•
Aruna Bio Announces Issuance of A New Composition of Matter Patent Covering Neural Exosomes in JapanUserwalls•Jun 13, 2022•Arunabio
•
Aruna Bio Advances Therapeutic Development for Traumatic Brain InjuryPR Newswire•Jun 01, 2022•Arunabio
•
ArunA Bio Appoints Stephen From as Chief Executive OfficerPR Newswire•Apr 28, 2022•Arunabio, Kiora Pharmaceuticals
•
•
Aruna Bio Appoints Dr. Renee Boerner as Vice President of Regulatory AffairsBusiness Wire•Nov 13, 2019•Arunabio
Are you a Founder ?
FAQs about Arunabio
Explore our recently published companies
- Vapl - India based, 2025 founded, Unfunded company
- WeGroup - Ghent based, 2017 founded, Series A company
- Mahavir Roads & Infrastructure - Mumbai based, 2010 founded, Unfunded company
- Indian Soya Industries - Indore based, 1968 founded, Unfunded company
- Shri Krishna Automobiles - Faridabad based, 1954 founded, Unfunded company
- Mahalaxmi Steels - Mumbai based, 1980 founded, Unfunded company